Cardiac Biomarkers Market, By Product Type (Myocardial Muscle Creatine Kinase, Myoglobin, Troponins, Brain Natriuretic Peptide or NT-proBNP, Ischemia-modified Albumin, and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), By Location of Testing (Laboratory Testing and Point of Care Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Cardiac biomarkers refer to proteins that are present in blood when the heart muscle is damaged or stressed. They help detect and monitor various heart conditions. The cardiac biomarkers market has been witnessing significant growth over the past few years driven by the rising incidence of cardiovascular diseases and growing elderly population worldwide who are more prone to cardiac issues. Furthermore, ongoing technological advancements are allowing for the development of more sensitive biomarkers that can enable the earlier detection of cardiac conditions.
Market Dynamics:
The global cardiac biomarkers market is driven by the increasing geriatric population, rising economic burden of cardiovascular diseases, growing adoption of point-of-care testing, and ongoing research & development. However, regulatory issues regarding the approval of new cardiac biomarkers, lack of awareness, and reluctant acceptance of new technologies pose challenges to market players. The market sees opportunities in developing economies due to increasing healthcare spending, growing diabetes and lifestyle disease burden, and emergence of local players. Key players are focusing on developing novel biomarker panels and portable testing devices for improved patient monitoring and management.
Key Features of the Study:
This report provides an in-depth analysis of the global cardiac biomarkers market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cardiac biomarkers market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, bioMérieux, and Becton, Dickinson and Company.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global cardiac biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac biomarkers market.
Detailed Segmentation-
By Product Type:
Myocardial Muscle Creatine Kinase (CK MB)
Myoglobin
Troponins (T and I)
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia-modified Albumin (IMA)
Others
By Application:
Myocardial Infarction 35.5
Congestive Heart Failure,
Acute Coronary Syndrome,
Atherosclerosis,
Others
Myocardial Infarction 35.5
Congestive Heart Failure,
By Location of Testing:
Laboratory Testing 70.1 %
Point of Care Testing
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles:
Abbott Laboratories
Life Diagnostics
Roche Diagnostics
Siemens Healthineers
Danaher Corporation
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
bioMérieux SA
Randox Laboratories Ltd.
Ortho Clinical Diagnostics
Myriad RBM
DiaDexus Inc.
Response Biomedical Corp.
BG Medicine, Inc.
Boston Scientific Corporation
Cardiovascular Systems, Inc.
Quidel Corporation
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Application
Market Snapshot, By Location of Testing
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter’s Analysis
4. Global Cardiac Biomarkers Market - Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the Market
5. Global Cardiac Biomarkers Market, By Product Type, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Myocardial Muscle Creatine Kinase (CK MB)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Myoglobin
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn) Myoglobin
Troponins (T and I)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Ischemia-modified Albumin (IMA)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
6. Global Cardiac Biomarkers Market, By Application, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Myocardial Infarction
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Congestive Heart Failure
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Acute Coronary Syndrome
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Atherosclerosis
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
7. Global Cardiac Biomarkers Market, By Location of Testing, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Laboratory Testing
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Point of Care Testing
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
8. Global Cardiac Biomarkers Market, By Region, 2019 – 2031, (USD Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2019–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profiles
Abbott Laboratories
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Life Diagnostics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Roche Diagnostics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Siemens Healthineers
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Danaher Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Becton, Dickinson and Company (BD)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
bioMérieux SA
Randox Laboratories Ltd.
Ortho Clinical Diagnostics
Myriad RBM
DiaDexus Inc.
Response Biomedical Corp.
BG Medicine, Inc.
Boston Scientific Corporation
Cardiovascular Systems, Inc.
Quidel Corporation
10. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. References and Research Methodology
References
Research Methodology
About Us and Sales Contact
*Browse 32 market data tables and 28 figures on Cardiac Biomarkers Market” - Global forecast to 2031